ACPE Activity Number: 0204-0000-26-405-H08-P Content Release Date: February 5, 2026 Expiration Date: October 31, 2026 Activity Type: Knowledge-based CE Credits: 0.5 contact hours (0.05 CEUs) Activity Fee: Free
Activity Overview
While there continues to be an epidemic of opioid-related overdose deaths, many patients experience acute or chronic pain, making it crucial for clinicians to understand how to appropriately treat pain, while reducing opioid-associated risks. Not all clinicians are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is essential in order to ensure that patients receive and understand the Medication Guides and information regarding the safe use of these products. This educational activity is highly relevant to interprofessional clinicians involved in the care of patients receiving opioid analgesic therapy, nonpharmacologic therapies, and non-opioid therapies for pain to appropriately manage pain and support the safe use of medication therapy for the treatment of pain.
This CE podcast will also highlight the value of the interprofessional team working together and the importance of frequent and open communication between healthcare professionals and with the patient and patient caregiver(s).
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Health-System Pharmacists designates this online activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was planned to meet the educational needs of physicians, pharmacists, physician associates and nurse practitioners (prescribers and non-prescribers) involved in the care of patients receiving opioid analgesic therapy, nonpharmacologic therapies, and non-opioid medication therapies.
Timothy J. Atkinson, PharmD, CPE is a Clinical Pharmacy Practitioner in Pain Management and federal employee working in pain and opioid policy development and dissemination. Dr. Atkinson specializes in complex and high-risk pain medication management. He was a residency director for a PGY-2 Pain and Palliative Care Pharmacy Residency program for many years and remains a strong advocate for expansion of clinical pharmacists with expertise in collaborative drug therapy management (CDTM) specific to pain management. Dr. Atkinson is a board member representing pain management for the Society of Pain and Palliative Care Pharmacists. Dr. Atkinson is the owner of Vanguard Pain Management Consulting where he advises clients in managed care and develops continuing education programs for pain management and substance use disorders.His research interests include opioids, buprenorphine, NSAIDs, pain management in specialty disease states, and the elderly.
Christopher M. Herndon, PharmD, BCACP Professor Southern Illinois University Edwardsville Edwardsville, Illinois
Christopher M. Herndon, PharmD, BCACP, FASHP, FCCP is a Professor with the Southern Illinois University Edwardsville (SIUE) School of Pharmacy. Currently, Dr. Herndon sees patients with chronic pain and opioid use disorder within a family medicine residency clinic. Dr. Herndon was the 2019 president for the Society of Pain and Palliative Care Pharmacists (SPPCP) and current president of the SPPCP Foundation. He is the 2006 recipient of the “Pain Champion Award” from the Alliance of State Pain Initiatives, the 2012 recipient of the “Academic Pain Educator of the Year Award” from the American Society of Pain Educators, the 2016 “Pharmacist of the Year” from the Illinois Pharmacist’s Association, and the 2018 recipient of the Distinguished Service Award from the American Pain Society.
Charles E. Argoff, MD Professor of Neurology, Director Pain Management Fellowship Albany Medical Center Director Comprehensive Pain Management Center Albany, New York
Charles E. Argoff, MD, is Professor of Neurology at Albany Medical College, Vice-Chair, Department of Neurology, Director of the Comprehensive Pain Center at Albany Medical Center and Director of the Pain Management Fellowship in Albany, NY. Dr. Argoff is a member of the American Academy of Neurology, the International Association for the Study of Pain, the American Academy of Pain Medicine, and the Eastern Pain Society and the New York State Pain Society. He is the Immediate Past President of the American Academy of Pain Medicine, the Past President of the American Academy of Pain Medicine Foundation, and Past President of the New York State Pain Society.
He is one of the editors of the recently published textbook Raj’s Practical Management of Pain, Sixth Edition, and co-author of Defeat Chronic Pain Now, a book written for people with chronic pain. He has recently published the fourth edition of Pain Management Secrets. He is on the editorial board for the Clinical Journal of Pain.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
·Christopher M. Herndon – Perrigo – direct ownership of stock
·Charles E. Argoff – Principal Investigator: AbbVie, Lilly, Lundbeck, Vertex
Speaker’s Bureau: AbbVie, Scilex, Lundbeck
Consultant: AbbVie, Scilex, Lundbeck, Vertex
All other persons in control of content do not have any relevant financial relationships with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.
Provided by ASHP
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Timothy J. Atkinson, PharmD, CPE, Activity Chair
Christopher M. Herndon, PharmD, BCACP
Charles E. Argoff, MD